Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Frontiers in Immunology|June 18, 2021
Premature Senescence and Increased Oxidative Stress in the Thymus of Down Syndrome PatientsGenni Enza Marcovecchio, Francesca Ferrua, Elena Fontana, et al.Cell Reports|September 30, 2014
Control of embryonic stem cell identity by BRD4-dependent transcriptional elongation of super-enhancer-associated pluripotency genesRaffaella Di Micco, Barbara Fontanals-Cirera, Vivien Low, et al.Cell Stem Cell|March 26, 2019
Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage ResponseGiulia Schiroli, Anastasia Conti, Samuele Ferrari, et al.Frontiers in Immunology|March 21, 2024
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cellsBeatrice Claudia Cianciotti, Zulma Irene Magnani, Alessia Ugolini, et al.Nature Communications|July 28, 2021
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosisRiccardo Biavasco, Emanuele Lettera, Kety Giannetti, et al.Molecular Cell|November 18, 2017
Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival GeneBarbara Fontanals-Cirera, Dan Hasson, Chiara Vardabasso, et al.Cancer Cell|July 12, 2011
miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasisAvital Gaziel-Sovran, Miguel F Segura, Raffaella Di Micco, et al.Nature Communications|March 8, 2023
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemiaMatteo Maria Naldini, Gabriele Casirati, Matteo Barcella, et al.Cell Reports. Medicine|June 4, 2025
Senescence and inflammation are unintended adverse consequences of CRISPR-Cas9/AAV6-mediated gene editing in hematopoietic stem cellsAnastasia Conti, Kety Giannetti, Federico Midena, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2026
Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells from Human Mobilized Peripheral Blood for Gene Therapy ApplicationsErika Zonari, Matteo Maria Naldini, Matteo Barcella, et al.Pageof 5